Literature DB >> 32978237

Preliminary predictive criteria for COVID-19 cytokine storm.

Roberto Caricchio1, Marcello Gallucci2, Chandra Dass3, Xinyan Zhang4, Stefania Gallucci5, David Fleece6, Michael Bromberg7, Gerard J Criner8.   

Abstract

OBJECTIVES: To develop predictive criteria for COVID-19-associated cytokine storm (CS), a severe hyperimmune response that results in organ damage in some patients infected with COVID-19. We hypothesised that criteria for inflammation and cell death would predict this type of CS.
METHODS: We analysed 513 hospitalised patients who were positive for COVID-19 reverse transcriptase PCR and for ground-glass opacity by chest high-resolution CT. To achieve an early diagnosis, we analysed the laboratory results of the first 7 days of hospitalisation. We implemented logistic regression and principal component analysis to determine the predictive criteria. We used a 'genetic algorithm' to derive the cut-offs for each laboratory result. We validated the criteria with a second cohort of 258 patients.
RESULTS: We found that the criteria for macrophage activation syndrome, haemophagocytic lymphohistiocytosis and the HScore did not identify the COVID-19 cytokine storm (COVID-CS). We developed new predictive criteria, with sensitivity and specificity of 0.85 and 0.80, respectively, comprising three clusters of laboratory results that involve (1) inflammation, (2) cell death and tissue damage, and (3) prerenal electrolyte imbalance. The criteria identified patients with longer hospitalisation and increased mortality. These results highlight the relevance of hyperinflammation and tissue damage in the COVID-CS.
CONCLUSIONS: We propose new early predictive criteria to identify the CS occurring in patients with COVID-19. The criteria can be readily used in clinical practice to determine the need for an early therapeutic regimen, block the hyperimmune response and possibly decrease mortality. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  antirheumatic agents; cytokines; immune system diseases; inflammation

Year:  2020        PMID: 32978237     DOI: 10.1136/annrheumdis-2020-218323

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  52 in total

Review 1.  COVID-19-related thyroid conditions (Review).

Authors:  Florica Șandru; Mara Carsote; Răzvan Cosmin Petca; Ancuta Augustina Gheorghisan-Galateanu; Aida Petca; Ana Valea; Mihai Cristian Dumitrașcu
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

Review 2.  The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations.

Authors:  Michael Schneider
Journal:  Biomark Insights       Date:  2022-06-26

Review 3.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

4.  Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients.

Authors:  Tamara Seitz; József Constantin Szeles; Reinhard Kitzberger; Johannes Holbik; Alexander Grieb; Hermann Wolf; Hüseyin Akyaman; Felix Lucny; Alexander Tychera; Stephanie Neuhold; Alexander Zoufaly; Christoph Wenisch; Eugenijus Kaniusas
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

5.  Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.

Authors:  Himanshu Dandu; Geeta Yadav; Hardeep Singh Malhotra; Saurabh Pandey; Ruovinuo Sachu; Kinjalk Dubey
Journal:  Int J Lab Hematol       Date:  2021-06-04       Impact factor: 3.450

6.  Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

Authors:  Lina Ghosn; Anna Chaimani; Theodoros Evrenoglou; Mauricia Davidson; Carolina Graña; Christine Schmucker; Claudia Bollig; Nicholas Henschke; Yanina Sguassero; Camilla Hansen Nejstgaard; Sonia Menon; Thu Van Nguyen; Gabriel Ferrand; Philipp Kapp; Carolina Riveros; Camila Ávila; Declan Devane; Joerg J Meerpohl; Gabriel Rada; Asbjørn Hróbjartsson; Giacomo Grasselli; David Tovey; Philippe Ravaud; Isabelle Boutron
Journal:  Cochrane Database Syst Rev       Date:  2021-03-18

7.  Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.

Authors:  Roberto Caricchio; Antonio Abbate; Ivan Gordeev; Jamie Meng; Priscilla Y Hsue; Tuhina Neogi; Roberto Arduino; Daria Fomina; Roman Bogdanov; Tatiana Stepanenko; Pilar Ruiz-Seco; Andrés Gónzalez-García; Yu Chen; Yuhan Li; Sarah Whelan; Stephanie Noviello
Journal:  JAMA       Date:  2021-07-20       Impact factor: 56.272

Review 8.  Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.

Authors:  Hongliang Zhang; Yujie Tang; Jinhui Tao
Journal:  Front Mol Biosci       Date:  2021-06-04

Review 9.  The signal pathways and treatment of cytokine storm in COVID-19.

Authors:  Lan Yang; Xueru Xie; Zikun Tu; Jinrong Fu; Damo Xu; Yufeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-07

Review 10.  Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity.

Authors:  Joseph Mercola; William B Grant; Carol L Wagner
Journal:  Nutrients       Date:  2020-10-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.